Article
30 Sep 2025
Enlarged Board Of Appeal Issues G2/24 Decision Without Oral Proceedings
AUTHORS CONTENT
Article
25 Aug 2025
Enlarged Board Of Appeal To Consider Referral On Description Amendments
Article
05 Aug 2025
Enlarged Board Of Appeal Asked To Consider The EPO's Approach To Amendment Of The Description
Article
23 Jun 2025
EPO's Enlarged Board Of Appeal Holds That The Description And Figures Should Always Be Considered When Interpreting The Claims
Article
16 May 2025
Sanofi & Regeneron v Amgen: The UPC Weighs In On Infringement Of Second Medical Use Claims
Article
15 Apr 2025
EPO To Use AI Tools To Prepare Minutes From VC Oral Proceedings
Article
19 Mar 2025
Date Set For Laos To Allow Validation Of European Patents As National Patents
Article
28 Feb 2025
Preliminary Opinion Issued For The Enlarged Board Of Appeal Case G 1/24 Regarding Use Of The Description When Interpreting The Claims
Article
07 Feb 2025
Previews Of The New EPO Guidelines For 2025 Have Now Been Published
Article
26 Dec 2024
Costa Rica Set To Allow Validation Of European Patents As National Patents
Article
22 Nov 2023
Disclaimer Practice At The EPO
Article
13 Oct 2023
The Exclusion From Patentability Of Surgical Methods At The European Patent Office
Article
04 Oct 2023
Double Patenting In The EPO
Article
15 Sep 2023
Patenting Polymorphs At The European Patent Office
Article
14 Sep 2023
European Patent Office Opposition Procedure
Article
14 Sep 2023
Orphan Drugs In The EU/EEA And UK
Article
14 Sep 2023
Data Exclusivity And Market Protection In The EU / EEA And UK
Article
14 Sep 2023
Introduction To Supplementary Protection Certificates For Medicinal Products
Article
14 Sep 2023
Does An SPC For A Biological Product Cover A Biosimilar?
Article
14 Sep 2023
Paediatric Extensions To Supplementary Protection Certificates In The EU / EEA And UK